Trial intelligence / Profile preview

Rowachol for Prevention of Postcholecystectomy Syndrome

NCT01765465Phase 4Completed

Sponsor
Dongguk University
Start
Jan 2013
Primary completion
May 2014
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

A Phase 4 trial of Rowachol in postcholecystectomy syndrome (PCS), sponsored by Dongguk University. Started Jan 2013; status: completed.

02

Drugs

Rowachol
03

Conditions

postcholecystectomy syndrome (PCS)

Beyond the preview

Go deeper on NCT01765465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01765465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call